When looking for the best stocks to buy and watch, focus on those with rising relative price strength.
One stock that fits that bill is Intercept Pharmaceutical stock, which saw a welcome improvement to its Relative Strength (RS) Rating on Tuesday, rising from 80 to 91.
When looking for the best stocks to buy and watch, one factor to watch closely is relative price strength. This unique rating identifies market leadership by showing how a stock's price action over the last 52 weeks measures up against that of the other stocks in our database.
Decades of market research reveals that the top-performing stocks tend to have an RS Rating of above 80 as they launch their biggest runs.
Looking For The Best Stocks To Buy And Watch? Start Here
Intercept Pharmaceutical Stock A Buy?
While it's not currently an ideal time to buy shares of Intercept Pharmaceutical stock, see if the stock is able to establish and enter a buy zone in heavy trade. Look for the stock market outlook to rally in a confirmed uptrend before adding stocks.
Earnings grew 10% last quarter, up from 0% in the prior report. Revenue also increased, from 3% to 5%.
Intercept Pharmaecutical stock holds the No. 100 rank among its peers in the Medical-Biomed/Biotech industry group. Catalyst Pharma, Vertex Pharmaceuticals and Amphastar Pharmaceutcls are among the top 5 highly rated stocks within the group. For more industry news, check out "Biotech And Pharmaceutical Industry And Stock News."
